FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to a pharmaceutical composition for treating diseases including cell proliferation, using it, and a kit containing the combined administration of a compound
EFFECT: preparing the pharmaceutical composition for treating diseases including cell proliferation.
5 cl, 8 dwg, 2 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
NEW N-SULFAMOYLPIPERIDINEAMIDS DESIGNED FOR PREVENTION OR TREATMENT OF FATTY DEGENERATION AND CONGENEROUS PATHOLOGICAL CONDITIONS | 2006 |
|
RU2442773C2 |
NEW CHEMICAL COMPOUNDS (VERSIONS) AND USING THEM FOR TREATING ONCOLOGICAL DISEASES | 2013 |
|
RU2550346C2 |
TRICYCLIC ANTITUMOR COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT BASED ON THEREOF | 2001 |
|
RU2293734C9 |
PYRIMIDINE COMPOUNDS OF ANTIPROLIFERATIVE ACTION (II) | 2003 |
|
RU2326882C2 |
MULTIKINASE INHIBITOR COMPOUND AND ITS CRYSTALLINE FORM AND USE | 2017 |
|
RU2723985C1 |
PYRIMIDINE INDOLE COMPOUNDS | 2010 |
|
RU2552999C2 |
COMPOUNDS, COMPOSITIONS AND METHODS SUITABLE FOR CHOLESTEROL MOBILISATION | 2011 |
|
RU2576402C2 |
CRYSTAL FORM OF PHOSPHODIESTERASE INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2020 |
|
RU2814498C2 |
PYRIDILAMINE FUMARATE AND ITS CRYSTALS | 2015 |
|
RU2684278C1 |
NOVEL CHEMICAL COMPOUNDS - 2,4-DIAMINO-1,3,5-TRIAZINE DERIVATIVES FOR PREVENTING AND TREATING HUMAN AND ANIMAL DISEASES | 2012 |
|
RU2509770C2 |
Authors
Dates
2014-06-27—Published
2005-08-09—Filed